中轴型脊柱关节炎共病患病率及影响的系统综述与荟萃分析
最常见的共病为高血压(合并患病率23%)、高脂血症(17%)和肥胖(14%),且11项研究一致显示axSpA患者共病患病率高于对照人群,抑郁(合并OR 1.80)和心力衰竭(OR 1.84)差异较大。共病总数及多种个体共病与axSpA疾病活动度、功能受损、生活质量、工作生产力和死亡率相关。
要点
- axSpA患者最常见共病为高血压(23%)、高脂血症(17%)和肥胖(14%)。
- axSpA患者共病患病率高于对照人群,抑郁(OR 1.80)和心力衰竭(OR 1.84)差异较大。
- 共病负担及多种个体共病与axSpA不良结局(疾病严重度、工作生产力、死亡率)相关。
核心结论
- 共病在axSpA中常见,尤其是心血管疾病及危险因素,且多数共病患病率高于对照人群。
- 总体共病负担及多种个体共病与axSpA不良结局相关,包括疾病严重度、工作生产力和死亡率。
研究设计与样本
- 系统检索Medline、PubMed、Scopus和Web of Science,遵循PRISMA指南,纳入40项研究进行分析。
- 采用随机效应模型进行荟萃分析,排除仅研究单一共病或同一器官系统内少数紧密相关疾病的研究。
主要发现
- 最常见的个体共病为高血压(合并患病率23%)、高脂血症(17%)和肥胖(14%)。
- 11项研究一致显示axSpA患者共病患病率高于对照人群,抑郁(合并OR 1.80)和心力衰竭(OR 1.84)差异较大。
- 共病总数及个体共病与axSpA疾病活动度、功能受损、生活质量、工作生产力和死亡率相关。
关键数值与推荐
- 高血压合并患病率23%,高脂血症17%,肥胖14%。
- 抑郁合并OR 1.80,心力衰竭OR 1.84(axSpA vs 对照)。
临床怎么用
- 风湿免疫科医生应关注axSpA患者的心血管疾病及危险因素(高血压、高脂血症、肥胖)的筛查与管理。
- 应评估axSpA患者的共病负担(包括抑郁和心力衰竭),因其与疾病活动度、功能、生活质量、工作生产力和死亡率相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Comorbidities are common in people with axial spondyloarthritis (axSpA). In this systematic review and meta-analysis, we aimed to: (i) describe the prevalence of commonly reported comorbidities, (ii) compare comorbidities between axSpA and control populations, and (iii) examine the impact of comorbidity burden on axSpA outcomes. METHODS: We systematically searched Medline, PubMed, Scopus and Web of Science using a predefined protocol in accordance with Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. We excluded studies of only one comorbid condition or a few closely related diseases within one organ system. Where possible, meta-analysis was performed using random-effects models. RESULTS: A total of 40 studies were included for analysis. 36 studies reported prevalence of comorbidities, amounting to a combined sample size of 119 427 patients. The number of comorbidities studied ranged from 3 to 43. The most prevalent individual comorbidities were hypertension (pooled prevalence 23%), hyperlipidaemia (17%) and obesity (14%). Eleven studies consistently showed higher prevalence of comorbidities in axSpA than controls, particularly large differences were seen for depression [pooled odds ratio (OR) 1.80] and heart failure (OR 1.84). Comorbidities (total number of and individual conditions) were also associated with axSpA disease activity, functional impairment, quality of life, work productivity and mortality. CONCLUSIONS: Comorbidities are common in axSpA, particularly cardiovascular diseases and risk factors. Most comorbidities were more prevalent in axSpA patients than in control populations. Overall comorbidity burden, and many individual conditions, were associated with axSpA outcomes including worse disease severity, work productivity and mortality.
引用
- Zhao SS, Robertson S, Reich T, et al. Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis. Rheumatology (Oxford). 2020. PMID: 33053193. doi:10.1093/rheumatology/keaa246
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。